Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
27.21
-1.19 (-4.19%)
Jul 24, 2026, 2:07 PM EDT - Market open
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $94.57 million as of July 24, 2026. Its market cap has increased by 555.61% in one year.
Market Cap
94.57M
Enterprise Value
116.07M
1-Year Change
555.61%
Ranking
Category
Stock Price
$27.21
ChartMarket Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $94.57M, an increase of 241.61%. That is a compound annual growth rate of 65.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 94.57M | -1.17% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Black Diamond Therapeutics | 101.42M |
| Entera Bio | 101.04M |
| Polaryx Therapeutics | 100.37M |
| Coya Therapeutics | 100.16M |
| ImmuCell | 99.51M |
| Oncolytics Biotech | 97.40M |
| Biomea Fusion | 91.82M |
| Aldeyra Therapeutics | 89.88M |